Akt and PTEN: New diagnostic markers of non-small cell lung cancer?

被引:19
|
作者
David, O [1 ]
机构
[1] Tulane Univ, Hlth Sci Ctr, New Orleans, LA 70112 USA
关键词
Akt; PTEN; cell survival; immunohistochemistry; lung cancer;
D O I
10.1111/j.1582-4934.2001.tb00178.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
We are particularly interested in testing the principles of cell proliferation and apoptosis in the microenvironment of human lung cancers with respect to the cell survival protein Akt (1) and PTEN (2). Akt is a cytosolic protein which promotes cell survival by phosphorylative inactivation of targets in apoptotic pathways. Akt has been found to play a role in the survival of experimental cancer cell lines in breast, prostate, ovary, lung and brain tissue. PTEN is a tumor suppressor gene whose protein product is expressed in inverse proportion to phosphorylated Akt in endometrial and breast cancer cell lines. No studies of the diagnostic significance of Akt and PTEN in human lung cancers have been reported.
引用
收藏
页码:430 / 433
页数:4
相关论文
共 50 条
  • [1] Diagnostic significance of Akt expression in non-small cell lung cancer
    David, O
    FASEB JOURNAL, 2002, 16 (05): : A1105 - A1106
  • [2] Therapeutic Implications of PTEN in Non-Small Cell Lung Cancer
    Sirhan, Zaid
    Alojair, Rawan
    Thyagarajan, Anita
    Sahu, Ravi P.
    PHARMACEUTICS, 2023, 15 (08)
  • [3] Identifying candidate diagnostic markers for early stage of non-small cell lung cancer
    Wu, Zhen
    Zhang, Xu
    Hei, Zhihui
    Hou, Liyun
    PLOS ONE, 2019, 14 (11):
  • [4] Diagnostic procedures in non-small cell lung cancer
    Kurz, S.
    Grohe, C.
    ONKOLOGE, 2018, 24 (12): : 952 - 957
  • [5] AKT and PTEN in non-small cell lung carcinomas-acting together or apart?
    Ardeleanu, C. M.
    Vasilescu, F.
    Iosif, C.
    Terzea, D.
    Georgescu, A. G. Mihaela
    Stoicea, M. C.
    Mihai, M.
    Andrei, F.
    Dobrea, C.
    Enache, S.
    Dumitrescu, M.
    VIRCHOWS ARCHIV, 2010, 457 (02) : 185 - 185
  • [6] Phosphorylated Akt overexpression and loss of PTEN expression in non-small cell lung cancer confers poor prognosis
    Tang, JM
    He, QY
    Guo, RX
    Chang, XJ
    LUNG CANCER, 2006, 51 (02) : 181 - 191
  • [7] Predictive molecular markers in non-small cell lung cancer
    Rosell, R
    Tarón, M
    O'Brate, A
    CURRENT OPINION IN ONCOLOGY, 2001, 13 (02) : 101 - 109
  • [8] Prognostic molecular markers in non-small cell lung cancer
    Niklinski, J
    Niklinska, W
    Laudanski, J
    Chyczewska, E
    Chyczewski, L
    LUNG CANCER, 2001, 34 : S53 - S58
  • [9] MARKERS OF PROLIFERATION ACTIVITY IN NON-SMALL CELL LUNG CANCER
    Vasutova, I.
    Skrickova, J.
    Stankova, Y.
    Babickova, L.
    Tomiskova, M.
    Kadlec, B.
    Pavlovsky, Z.
    Kren, L.
    Chroust, K.
    LUNG CANCER, 2009, 64 : S30 - S31
  • [10] MOLECULAR MARKERS IN NON-SMALL CELL LUNG CANCER (NSCLC)
    Heigener, D.
    ANTICANCER RESEARCH, 2011, 31 (05) : 1979 - 1979